Zavras, P., Wang, Y., Gandhi, A., Lontos, K., & Delgoffe, G. (2019). Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: Evidence to date. Onco Targets Ther.
Chicago ZitierstilZavras, PD, Y. Wang, A. Gandhi, K. Lontos, und GM Delgoffe. "Evaluating Tisagenlecleucel and Its Potential in the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma: Evidence to Date." Onco Targets Ther 2019.
MLA ZitierstilZavras, PD, et al. "Evaluating Tisagenlecleucel and Its Potential in the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma: Evidence to Date." Onco Targets Ther 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.